Siegfried Holding AG

Company Overview

Siegfried is a manufacturing and contract development company that operates 13 production facilities across three continents. It brings innovations to the industrial scale using its extensive experience in the chemical and pharmaceutical industries. Siegfried provides contract development and manufacturing services for pharmaceutical intermediates, finished dosage forms and active ingredients. Because of their integrated approach, they are able to offer a wide range of services under one roof, including registration, production, packaging and logistics, in addition to process development and optimization.

Siegfried produces finished dosage forms (Drug Products) and active pharmaceutical ingredients and intermediates (Drug Substances) through a global network spanning seven nations on three continents. About 200 of the 1,500 APIs that the FDA has approved are supplied by Siegfried. The company provides services for over 500 clients worldwide. It produced more than 100 million doses of Covid-19 vaccinations.

Financial Highlights (FY 2024)

Company's Business Segments

• Drug Substances : Exclusive Synthesis, Portfolio Offering, Others
• Drug Products : Steriles, Ophthalmics, Inhalation Products, Oral Solid Dosage Forms, Viral Vectors, Others